Inhibition of IRAK1 As a Novel Therapeutic Strategy in Acute Myeloid Leukemia and Myelodysplastic Syndrome

被引：0
|
作者：
Rhyasen, Garrett [1 ]
Bolanos, Lyndsey [1 ]
Fang, Jing [1 ]
Rigolino, Carmen [2 ]
Cortelezzi, Agostino [3 ,4 ]
Oliva, Esther Natalie [5 ]
Cuzzola, Mariella [2 ]
Starczynowski, Daniel T. [1 ]
机构：
[1] Cincinnati Childrens Hosp, Med Ctr, Cincinnati, OH USA
[2] Azienda Osped, Bone Marrow Transplant Unit, Reggio Di Calabria, Italy
[3] IRCCS Fdn Ca Granda, Milan, Italy
[4] Univ Milan, Milan, Italy
[5] Azienda Osped BMM, Hematol Unit, Reggio Di Calabria, Italy
来源：
BLOOD | 2011年 / 118卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：281 / 281
页数：1
相关论文
共 50 条
  • [31] Molecular Genetics in Myelodysplastic Syndrome and Acute Myeloid Leukemia
    Carol Westbrook
    Pediatric Research, 1999, 45 : 747 - 747
  • [32] Autophagy in the pathogenesis of myelodysplastic syndrome and acute myeloid leukemia
    Watson, Alexander Scarth
    Mortensen, Monika
    Simon, Anna Katharina
    CELL CYCLE, 2011, 10 (11) : 1719 - 1725
  • [33] Acute Myeloid Leukemia and Myelodysplastic Syndrome with MYC Rearrangement
    Wang, Xiaoqiong
    Tang, Guilin
    Hu, Zhihong
    Wang, Wei
    Toruner, Gokce
    Tang, Zhenya
    Bueso-Ramos, Carlos
    Medeiros, L. Jeffrey
    Hu, Shimin
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 903 - 904
  • [34] Acute Myeloid Leukemia and Myelodysplastic Syndrome with MYC Rearrangement
    Wang, Xiaoqiong
    Tang, Guilin
    Hu, Zhihong
    Wang, Wei
    Toruner, Gokce
    Tang, Zhenya
    Bueso-Ramos, Carlos
    Medeiros, L. Jeffrey
    Hu, Shimin
    MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 903 - 904
  • [35] Treatment of acute myeloid leukemia with antecedent myelodysplastic syndrome
    Larson, RA
    LEUKEMIA, 1996, 10 : S23 - S25
  • [36] IDH Inhibitors in Acute Myeloid Leukemia and Myelodysplastic Syndrome
    Stein, Eytan M.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (09) : 556 - 558
  • [37] Pharmacologic ROCK1-inhibition as potential novel therapeutic approach in acute myeloid leukemia
    Frimmel, J.
    Camgoz, A.
    von Bonin, M.
    Paszkowski-Rogacz, M.
    Kuhnert, R.
    Bornhaeuser, M.
    Buchholz, F.
    Wermke, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 78 - 79
  • [38] Targeted Inhibition of STAT/TET1 Axis As a Potent Therapeutic Strategy for Acute Myeloid Leukemia
    Jiang, Xi
    Hu, Chao
    Ferchen, Kyle
    Nie, Ji
    Cui, Xiaolong
    Chen, Chih-Hong
    Cheng, Liting
    Zuo, Zhixiang
    Seibel, William
    He, Chunjiang
    Tang, Yixuan
    Skibbe, Jennifer R.
    Wunderlich, Mark
    Reinhold, William C.
    Dong, Lei
    Shen, Chao
    Arnovitz, Stephen
    Ulrich, Bryan
    Lu, Jiuwei
    Weng, Hengyou
    Su, Rui
    Huang, Huilin
    Wang, Yungui
    Li, Chenying
    Qin, Xi
    Mulloy, James C.
    Zheng, Yi
    Diao, Jiajie
    Jin, Jie
    Li, Chong
    Liu, Paul P.
    He, Chuan
    Chen, Yuan
    Chen, Jianjun
    BLOOD, 2017, 130
  • [39] IRAK1, a potential therapeutic target for rheumatoid arthritis?
    Xie, Qiang
    Wang, Shi-Cun
    Li, Jun
    RHEUMATOLOGY INTERNATIONAL, 2013, 33 (12) : 3069 - 3070
  • [40] Immune Checkpoint Inhibition in Acute Myeloid Leukemia and Myelodysplastic Syndromes
    Abaza, Yasmin
    Zeidan, Amer M.
    CELLS, 2022, 11 (14)
12345